In contrast, certainty of evidence for tirzepatide compared to placebo at the agent-level was consistently low across outcomes, primarily driven by indirect-only evidence and concerns related to transitivity, with additional downgrading for imprecision or heterogeneity in select endpoints (Supplementary Table S25)
The trial is registered with ClinicalTrials.gov under NCT03693430, lending further credibility to these findings
Clinically, the results of the injectable and oral formulations are comparable, with the main difference being how the medication enters the bloodstream
It suggests a need to check things out and make supportive changes rather than stopping medication altogether in most situations
The recipes work for people taking Mounjaro (tirzepatide), Wegovy (semaglutide), Saxenda (liraglutide), or Ozempic (semaglutide)
4,9 References Celletti, F., Farrar, J., & De Regil, L